The autoinhibitory C-terminal SH2 domain of phospholipase C-γ2 stabilizes B cell receptor signalosome assembly.

The binding of antigen to the B cell receptor (BCR) stimulates the assembly of a signaling complex (signalosome) composed initially of the kinases Lyn, spleen tyrosine kinase (Syk), and Bruton's tyrosine kinase (Btk), as well as the adaptor protein B cell linker (BLNK). Together, these proteins recruit and activate phospholipase C-gamma 2 (PLC-gamma 2), a critical effector that stimulates increases in intracellular Ca2+ and activates various signaling pathways downstream of the BCR. Individuals with one copy of a mutant PLCG2 gene, which encodes a variant PLC-gamma 2 that lacks the autoinhibitory C-terminal Src homology 2 (cSH2) domain, exhibit PLC-gamma 2-associated antibody deficiency and immune dysregulation (PLAID). Paradoxically, although COS-7 cells expressing the variant PLC-gamma 2 show enhanced basal and stimulated PLC-gamma 2 activity, B cells from PLAID patients show defective intracellular Ca2+ responses upon cross-linking of the BCR. We found that the cSH2 domain of PLC-gamma 2 played a critical role in stabilizing the early signaling complex that is stimulated by BCR cross-linking. In the presence of the variant PLC-gamma 2, Syk, Btk, and BLNK were only weakly phosphorylated and failed to stably associate with the BCR. Thus, BCRs could not form stable clusters, resulting in dysregulation of downstream signaling and trafficking of the BCR. Thus, the cSH2 domain functions not only to inhibit the active site of PLC-gamma 2 but also to directly or indirectly stabilize the early BCR signaling complex.